AAME vs GL vs CNO vs MMC

For growth investors, Marsh & McLennan Companies, Inc.

(MMC) is the stronger pick with 7. 6% revenue growth year-over-year, versus 0. 8% for Atlantic American Corporation (AAME). Globe Life Inc. (GL) offers the better valuation at 10. 8x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate Globe Life Inc. (GL) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Globe Life Inc.

(GL) is the cheapest at 10. 8x versus Marsh & McLennan Companies, Inc. at 21. 3x. On forward P/E, Globe Life Inc. is actually cheaper at 9. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Globe Life Inc. wins at 0. 63x versus CNO Financial Group, Inc. 's 4. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, CNO Financial Group, Inc.

(CNO) delivered a total return of +81. 9%, compared to -33. 5% for Atlantic American Corporation (AAME). Over 10 years, the gap is even starker: MMC returned +209. 8% versus AAME's -33. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Marsh & McLennan Companies, Inc.

(MMC) is the lower-risk stock at 0. 14β versus CNO Financial Group, Inc. 's 0. 80β — meaning CNO is approximately 484% more volatile than MMC relative to the S&P 500. On balance sheet safety, Atlantic American Corporation (AAME) carries a lower debt/equity ratio of 38% versus 162% for Marsh & McLennan Companies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Marsh & McLennan Companies, Inc.

(MMC) is pulling ahead at 7. 6% versus 0. 8% for Atlantic American Corporation (AAME). On earnings-per-share growth, the picture is similar: Globe Life Inc. grew EPS 17. 8% year-over-year, compared to -724. 4% for Atlantic American Corporation. Over a 3-year CAGR, CNO leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Globe Life Inc.

(GL) is the more profitable company, earning 19. 4% net margin versus -2. 3% for Atlantic American Corporation — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GL leads at 24. 4% versus -2. 8% for AAME. At the gross margin level — before operating expenses — CNO leads at 44. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Globe Life Inc. (GL) is the more undervalued stock at a PEG of 0. 63x versus CNO Financial Group, Inc. 's 4. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Globe Life Inc. (GL) trades at 9. 8x forward P/E versus 16. 9x for Marsh & McLennan Companies, Inc. — 7. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMC: 18. 8% to $206. 75.

All stocks in this comparison pay dividends.

Marsh & McLennan Companies, Inc. (MMC) offers the highest yield at 1. 8%, versus 0. 7% for Globe Life Inc. (GL).

For long-horizon retirement investors, Marsh & McLennan Companies, Inc.

(MMC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 8% yield, +209. 8% 10Y return). Both have compounded well over 10 years (MMC: +209. 8%, CNO: +171. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AAME is a small-cap quality compounder stock; GL is a mid-cap deep-value stock; CNO is a small-cap quality compounder stock; MMC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.